Item 5.07 Submission of Matters to a Vote of Security Holders

The Annual Meeting of Stockholders (the "Annual Meeting") of Bionik Laboratories Corp. (the "Company") was held on January 19, 2023. At the Annual Meeting, the stockholders of the Company voted on the following two proposals and cast their votes as described below. The proposals are described in more detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on December 7, 2022.

Proposal 1: Election of the seven nominees listed below to serve on the Board of Directors of the Company until the next Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified:





Nominee              For       Withhold Authority Broker Non-votes
Andre Auberton-Herve 3,489,934 7,803              75,827
Remi Gaston-Dreyfus  3,490,768 6,969              75,827
Rich Russo Jr.       3,493,270 4,467              75,827
Joseph Martin        3,490,768 6,969              75,827
Charles Matine       3,490,768 6,969              75,827
Audrey Thevenon      3,490,768 6,969              75,827
Michal Prywata       3,490,768 6,969              75,827

Proposal 2: To ratify MNP, LLP as the Company's independent public accountants for the year ending March 31, 2023.





For       Against Abstain
3,566,547 5,337   1,680

Item 9.01 Financial Statements and Exhibits.





Exhibit    Description
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses